Search





Search





Markets
/
Stocks
/
stok
/

Stoke Therapeutics Inc

STOK

Add to Watchlist

29.320USD

+0.020+0.07%

Close 07-27 16:00（ET）Quotes delayed by 15 min

1.73BMarket Cap

LossP/E TTM

Stoke Therapeutics Inc

29.320

+0.020+0.07%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

STOK Cash Flow Statement

You can access the annual and quarterly cash flow statements of Stoke Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-145.96%-60.58M

-31.31%-30.45M

-40.49%-30.37M

-45.46%-25.42M

636.62%131.83M

-12.32%-23.19M

-25.22%-21.61M

19.83%-17.48M

-15.03%-24.57M

7.71%-20.65M

21.74%-17.26M

-9.39%-21.80M

-165.73%-21.36M

-37.61%-22.37M

-50.22%-22.06M

-25.88%-19.93M

261.36%32.49M

-48.73%-16.26M

-35.03%-14.68M

-64.12%-15.83M

-86.95%-20.14M

-7.16%-10.93M

-35.10%-10.87M

-53.75%-9.65M

-64.90%-10.77M

-190.21%-10.20M

-164.65%-8.05M

-159.36%-6.27M

-228.41%-6.53M

---3.52M

---3.04M

---2.42M

---1.99M

Net income from continuing operations

-144.30%-50.00M

-452.70%-57.93M

-45.09%-38.35M

8.61%-23.48M

527.99%112.88M

61.12%-10.48M

-7.69%-26.43M

16.18%-25.70M

-16.98%-26.37M

-5.08%-26.96M

6.01%-24.54M

-24.35%-30.65M

8.54%-22.55M

-4.94%-25.66M

-15.55%-26.11M

-12.22%-24.65M

-46.78%-24.65M

-67.90%-24.45M

-65.13%-22.60M

-69.51%-21.97M

-52.12%-16.79M

-43.32%-14.56M

-59.04%-13.68M

-65.74%-12.96M

-92.25%-11.04M

-137.27%-10.16M

-159.39%-8.60M

-159.77%-7.82M

-200.31%-5.74M

---4.28M

---3.32M

---3.01M

---1.91M

Operating gains losses

-7.97%439.00K

-23.00%405.00K

110.74%1.14M

-18.61%446.00K

-15.28%477.00K

-15.71%526.00K

-15.23%540.00K

-10.31%548.00K

-5.70%563.00K

2.46%624.00K

64.18%637.00K

102.32%611.00K

141.70%597.00K

159.15%609.00K

52.76%388.00K

21.29%302.00K

4.66%247.00K

-0.84%235.00K

8.55%254.00K

11.16%249.00K

22.28%236.00K

70.50%237.00K

85.71%234.00K

113.33%224.00K

141.25%193.00K

85.33%139.00K

96.88%126.00K

144.19%105.00K

150.00%80.00K

--75.00K

--64.00K

--43.00K

--32.00K

Other non-cash items

131.43%243.00K

149.50%99.00K

-383.33%-68.00K

317.22%1.14M

-80.04%105.00K

-139.84%-200.00K

-94.56%24.00K

-33.41%273.00K

-9.62%526.00K

28.06%502.00K

1.61%441.00K

20.59%410.00K

-4.90%582.00K

-11.51%392.00K

16.98%434.00K

8.28%340.00K

125.83%612.00K

66.54%443.00K

41.60%371.00K

22.18%314.00K

7.11%271.00K

--266.00K

--262.00K

--257.00K

--253.00K

----

Change in working capital

-272.34%-20.01M

184.13%16.98M

65.49%-1.12M

-36976.67%-11.12M

347.56%11.61M

-2205.83%-20.18M

-823.93%-3.24M

-102.80%-30.00K

20.18%-4.69M

75.06%-875.00K

86.97%-351.00K

151.56%1.07M

-111.45%-5.88M

-224.17%-3.51M

-200.64%-2.69M

-285.64%-2.08M

880.08%51.31M

82.68%2.83M

404.91%2.68M

-5.24%1.12M

-603.42%-6.58M

273.43%1.55M

276.08%530.00K

3.59%1.18M

11.29%-935.00K

-258.44%-892.00K

-275.00%-301.00K

142.46%1.14M

-832.74%-1.05M

--563.00K

--172.00K

--471.00K

---113.00K

-Change in receivables

--1.49M

--3.31M

---7.58M

----

-Change in prepaid expenses

-40.43%-3.59M

115.25%220.00K

840.00%5.64M

-497.83%-3.85M

-632.09%-2.56M

-206.65%-1.44M

216.73%600.00K

-136.22%-644.00K

83.29%-349.00K

188.55%1.35M

-188.47%-514.00K

283.11%1.78M

36.05%-2.09M

-96.40%-1.53M

154.82%581.00K

20.61%-971.00K

-202.88%-3.27M

72.44%-778.00K

385.00%228.00K

-228.87%-1.22M

-16.67%-1.08M

-427.11%-2.82M

95.71%-80.00K

521.78%949.00K

-16.08%-924.00K

363.91%863.00K

-609.51%-1.87M

-118.45%-225.00K

-1404.92%-796.00K

---327.00K

---263.00K

---103.00K

--61.00K

-Change in payables and accrued expense

-431.55%-15.72M

308.54%8.90M

751.67%4.88M

-22.70%2.77M

347.06%4.74M

289.64%2.18M

-137.13%-749.00K

180.80%3.58M

-646.72%-1.92M

-677.39%-1.15M

249.85%2.02M

-517.64%-4.43M

110.19%351.00K

-94.48%199.00K

-154.98%-1.35M

-54.78%1.06M

37.39%-3.44M

-17.53%3.60M

301.31%2.45M

901.71%2.34M

-49890.91%-5.50M

348.15%4.37M

-60.82%610.00K

-82.79%234.00K

95.85%-11.00K

-296.32%-1.76M

257.11%1.56M

136.52%1.36M

-53.18%-265.00K

--897.00K

--436.00K

--575.00K

---173.00K

-Change in other current liabilities

-123.26%-2.19M

121.71%4.54M

-31.22%-4.06M

-238.78%-10.04M

489.06%9.43M

-1838.09%-20.91M

-66.88%-3.09M

-179.61%-2.96M

41.47%-2.42M

50.50%-1.08M

3.84%-1.85M

271.52%3.72M

-107.14%-4.14M

---2.18M

---1.93M

---2.17M

--58.01M

----

-100.00%0.00

----

185.71%6.00K

900.00%8.00K

800.00%7.00K

---7.00K

---1.00K

Cash from non-recurring investing activities

Cash from operating activities

-145.96%-60.58M

-31.31%-30.45M

-40.49%-30.37M

-45.46%-25.42M

636.62%131.83M

-12.32%-23.19M

-25.22%-21.61M

19.83%-17.48M

-15.03%-24.57M

7.71%-20.65M

21.74%-17.26M

-9.39%-21.80M

-165.73%-21.36M

-37.61%-22.37M

-50.22%-22.06M

-25.88%-19.93M

261.36%32.49M

-48.73%-16.26M

-35.03%-14.68M

-64.12%-15.83M

-86.95%-20.14M

-7.16%-10.93M

-35.10%-10.87M

-53.75%-9.65M

-64.90%-10.77M

-190.21%-10.20M

-164.65%-8.05M

-159.36%-6.27M

-228.41%-6.53M

---3.52M

---3.04M

---2.42M

---1.99M

Investing cash flow

Net cash from continuing investing activities

132.24%353.00K

452.38%232.00K

28.16%132.00K

234.78%154.00K

1166.67%152.00K

-81.66%42.00K

-73.11%103.00K

-94.52%46.00K

-92.73%12.00K

-44.01%229.00K

-81.13%383.00K

23.02%839.00K

-80.38%165.00K

101.48%409.00K

643.59%2.03M

31.15%682.00K

312.25%841.00K

125.56%203.00K

1.49%273.00K

541.98%520.00K

-66.56%204.00K

-84.18%90.00K

-53.86%269.00K

-79.34%81.00K

577.78%610.00K

585.54%569.00K

12.98%583.00K

30.67%392.00K

246.15%90.00K

--83.00K

--516.00K

--300.00K

--26.00K

Capital expenditures

132.24%353.00K

452.38%232.00K

28.16%132.00K

234.78%154.00K

1166.67%152.00K

-81.66%42.00K

-73.11%103.00K

-94.52%46.00K

-92.73%12.00K

-44.01%229.00K

-81.13%383.00K

23.02%839.00K

-80.38%165.00K

101.48%409.00K

643.59%2.03M

31.15%682.00K

312.25%841.00K

125.56%203.00K

1.49%273.00K

541.98%520.00K

-66.56%204.00K

-84.18%90.00K

-53.86%269.00K

-79.34%81.00K

563.04%610.00K

511.83%569.00K

12.98%583.00K

30.67%392.00K

253.85%92.00K

--93.00K

--516.00K

--300.00K

--26.00K

Net cash flow from disposal of fixed assets

132.24%353.00K

452.38%232.00K

28.16%132.00K

234.78%154.00K

1166.67%152.00K

-81.66%42.00K

-73.11%103.00K

-94.52%46.00K

-92.73%12.00K

-44.01%229.00K

-81.13%383.00K

23.02%839.00K

-80.38%165.00K

101.48%409.00K

643.59%2.03M

31.15%682.00K

312.25%841.00K

125.56%203.00K

1.49%273.00K

541.98%520.00K

-66.56%204.00K

-84.18%90.00K

-53.86%269.00K

-79.34%81.00K

577.78%610.00K

585.54%569.00K

12.98%583.00K

30.67%392.00K

246.15%90.00K

--83.00K

--516.00K

--300.00K

--26.00K

Net cash flow from investment products

270.34%51.05M

-7164.92%-60.83M

130.86%9.23M

-68.11%-148.32M

37.84%13.78M

-94.26%861.00K

-299.34%-29.90M

-462.92%-88.23M

-81.22%10.00M

-34.49%15.00M

-78.35%15.00M

2836.23%24.31M

139.46%53.25M

90.83%22.90M

1488.38%69.29M

101.01%828.00K

---134.94M

--12.00M

---4.99M

---82.23M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

271.88%50.69M

-7555.56%-61.06M

130.31%9.09M

-68.19%-148.48M

36.48%13.63M

-94.46%819.00K

-305.27%-30.00M

-476.08%-88.28M

-81.18%9.99M

-34.32%14.77M

-78.27%14.62M

15977.40%23.47M

139.10%53.09M

90.64%22.49M

1377.81%67.26M

100.18%146.00K

-66459.80%-135.78M

13207.78%11.80M

-1856.88%-5.26M

-102066.67%-82.75M

66.56%-204.00K

84.18%-90.00K

53.86%-269.00K

79.34%-81.00K

-577.78%-610.00K

-585.54%-569.00K

-12.98%-583.00K

-30.67%-392.00K

-246.15%-90.00K

---83.00K

---516.00K

---300.00K

---26.00K

Financing cash flow

Cash flow from continuous financing activities

6037.34%84.33M

16157.22%92.34M

-61.76%3.12M

-99.54%554.00K

-19.98%1.37M

-92.26%568.00K

1351.78%8.16M

251254.17%120.65M

-96.19%1.72M

16976.74%7.34M

29.49%562.00K

-98.60%48.00K

5.99%45.05M

-74.85%43.00K

6.37%434.00K

2054.09%3.42M

7685.16%42.51M

-99.84%171.00K

-39.38%408.00K

-56.91%159.00K

175.76%546.00K

55560.42%106.87M

167.30%673.00K

-99.76%369.00K

391.18%198.00K

-99.79%192.00K

-107.47%-1.00M

239007.94%150.64M

-100.55%-68.00K

--89.78M

--13.38M

--63.00K

--12.42M

Net cash flow from common stock issuance/repurchase

----

--0.00

--119.88M

----

--105.40M

--0.00

----

--0.00

--151.91M

----

--0.00

----

Net cash flow from preferred stock issuance/repurchase

----

-100.00%0.00

--90.15M

--13.37M

--63.00K

--12.41M

Proceeds from stock option exercised by employees

167.10%3.67M

703.70%4.56M

520.28%3.12M

-27.68%554.00K

228.71%1.37M

11240.00%567.00K

-10.50%503.00K

1495.83%766.00K

34.41%418.00K

-88.10%5.00K

29.49%562.00K

-85.28%48.00K

18.70%311.00K

-75.58%42.00K

6.63%434.00K

102.48%326.00K

-52.01%262.00K

-89.22%172.00K

-60.60%407.00K

-56.25%161.00K

174.37%546.00K

722.16%1.59M

5336.84%1.03M

1214.29%368.00K

168.92%199.00K

4750.00%194.00K

171.43%19.00K

--28.00K

825.00%74.00K

--4.00K

--7.00K

--0.00

--8.00K

Net cash flow from other financing activities

--80.66M

8778300.00%87.78M

----

-100.00%0.00

-99.99%1.00K

--7.66M

--0.00

-97.10%1.30M

733700.00%7.34M

--0.00

-100.00%0.00

5.91%44.74M

200.00%1.00K

-100.00%0.00

155050.00%3.10M

--42.24M

99.20%-1.00K

100.28%1.00K

-300.00%-2.00K

----

-6150.00%-125.00K

64.67%-360.00K

100.08%1.00K

99.30%-1.00K

99.47%-2.00K

-101800.00%-1.02M

---1.30M

-14100.00%-142.00K

---378.00K

---1.00K

--0.00

---1.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

6037.34%84.33M

16157.22%92.34M

-61.76%3.12M

-99.54%554.00K

-19.98%1.37M

-92.26%568.00K

1351.78%8.16M

251254.17%120.65M

-96.19%1.72M

16976.74%7.34M

29.49%562.00K

-98.60%48.00K

5.99%45.05M

-74.85%43.00K

6.37%434.00K

2054.09%3.42M

7685.16%42.51M

-99.84%171.00K

-39.38%408.00K

-56.91%159.00K

175.76%546.00K

55560.42%106.87M

167.30%673.00K

-99.76%369.00K

391.18%198.00K

-99.79%192.00K

-107.47%-1.00M

239007.94%150.64M

-100.55%-68.00K

--89.78M

--13.38M

--63.00K

--12.42M

Net cash flow

Beginning cash balance

-34.04%84.94M

-44.14%84.11M

-47.30%102.27M

53.84%275.61M

-32.93%128.78M

-20.97%150.59M

0.74%194.04M

-6.16%179.15M

68.25%192.01M

67.20%190.55M

181.94%192.63M

125.45%190.91M

-21.54%114.13M

-23.90%113.97M

-59.64%68.32M

-68.37%84.68M

-49.41%145.46M

-21.87%149.75M

-16.25%169.29M

26.59%267.72M

29.12%287.51M

-17.83%191.67M

-16.78%202.13M

113.82%211.49M

110.86%222.68M

1100.98%233.25M

2429.53%242.88M

706.93%98.91M

5599.03%105.60M

--19.42M

--9.60M

--12.26M

--1.85M

Current period cash flow changes

-49.30%74.44M

103.79%826.00K

58.23%-18.15M

-1263.78%-173.34M

1241.69%146.83M

-1588.46%-21.81M

-1986.41%-43.46M

765.49%14.89M

-116.75%-12.86M

815.63%1.47M

-104.56%-2.08M

110.52%1.72M

226.32%76.78M

103.73%160.00K

333.61%45.64M

83.38%-16.36M

-207.08%-60.78M

-104.48%-4.29M

-86.63%-19.54M

-951.80%-98.43M

-77.00%-19.79M

1006.10%95.85M

-8.70%-10.47M

-106.50%-9.36M

-67.16%-11.18M

-112.27%-10.58M

-198.07%-9.63M

5520.63%143.97M

-164.30%-6.69M

--86.18M

--9.82M

---2.66M

--10.40M

Ending cash balance

-42.17%159.38M

-34.04%84.94M

-44.14%84.11M

-47.30%102.27M

53.84%275.61M

-32.93%128.78M

-20.97%150.59M

0.74%194.04M

-6.16%179.15M

68.25%192.01M

67.20%190.55M

181.94%192.63M

125.45%190.91M

-21.54%114.13M

-23.90%113.97M

-59.64%68.32M

-68.37%84.68M

-49.41%145.46M

-21.87%149.75M

-16.25%169.29M

26.59%267.72M

29.12%287.51M

-17.83%191.67M

-16.78%202.13M

113.82%211.49M

110.86%222.68M

1100.92%233.25M

2429.53%242.88M

706.99%98.91M

--105.60M

--19.42M

--9.60M

--12.26M

Free cash flow

-146.28%-60.94M

-32.07%-30.69M

-40.43%-30.50M

-45.96%-25.58M

635.74%131.68M

-11.29%-23.23M

-23.08%-21.72M

22.60%-17.52M

-14.20%-24.58M

8.36%-20.88M

26.74%-17.64M

-9.84%-22.64M

-168.00%-21.52M

-38.40%-22.78M

-61.06%-24.09M

-26.05%-20.61M

255.60%31.65M

-49.36%-16.46M

-34.22%-14.96M

-68.10%-16.35M

-78.72%-20.34M

-2.33%-11.02M

-29.09%-11.14M

-45.92%-9.73M

-71.81%-11.38M

-198.50%-10.77M

-142.65%-8.63M

-145.16%-6.67M

-228.73%-6.62M

---3.61M

---3.56M

---2.72M

---2.02M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Stoke Therapeutics Inc Generate?



Stoke Therapeutics Inc generated 45.59M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Stoke Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Stoke Therapeutics Inc's operating cash flow increased by 152.49% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Stoke Therapeutics Inc Spend on Capital Expenditures?



Stoke Therapeutics Inc spent 670.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Stoke Therapeutics Inc's Financing Cash Flow Changed?



Stoke Therapeutics Inc used 97.39M in financing activities in the latest quarter.

What is free cash flow and why does it matter for STOK?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Stoke Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was 44.91M reflecting a 151.59% change from the previous year.